Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Hepatocellular
  • Chemoembolization, Therapeutic
  • Doxorubicin
  • Liver Neoplasms

abstract

  • There was no apparent difference between the treatment arms. These results challenge the use of doxorubicin-eluting beads for chemoembolization of HCC.

publication date

  • June 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4966514

Digital Object Identifier (DOI)

  • 10.1200/JCO.2015.64.0821

PubMed ID

  • 26834067

Additional Document Info

start page

  • 2046

end page

  • 53

volume

  • 34

number

  • 17